Trazodone for Children Under 12: Caregiver Administration Guidance

At a glance
- FDA status / not approved for any pediatric indication; all use in children under 12 is off-label
- Typical off-label sleep dose / 1 to 2 mg/kg/day, usually 25 to 50 mg, given 30 to 60 min before bed
- Formulations available / 50 mg, 100 mg, 150 mg, and 300 mg scored tablets; no commercial pediatric liquid
- Onset of sedation / roughly 30 to 60 minutes after oral ingestion
- Half-life in children / approximately 5 to 9 hours (shorter than the adult range of 5 to 13 hours)
- Black-box warning / increased risk of suicidal thinking in pediatric and young adult patients
- Most common caregiver-reported side effects / morning grogginess, dry mouth, dizziness on standing
- When to call 911 / priapism, seizure, loss of consciousness, or allergic reaction
Why Trazodone Is Used in Young Children
Trazodone is an FDA-approved antidepressant for adults, but in children under 12 it is prescribed almost entirely off-label, most often for sleep-onset insomnia that has not responded to behavioral strategies. Prescribers choose it because the sedating properties arrive at doses well below those needed for antidepressant effect, and because it carries a lower respiratory-depression risk than antihistamines or benzodiazepines.
The Regulatory and Evidence Gap
The FDA has not approved trazodone for any pediatric indication. The agency's drug label for trazodone hydrochloride does not include pediatric dosing tables, and the label explicitly notes that safety and efficacy in the pediatric population have not been established. [1] Controlled trial data for children under 12 are sparse. A 2016 systematic review in Pediatrics found that nearly all pharmacological sleep interventions in children rely on low-quality evidence, with most studies running fewer than four weeks. [2]
That evidence gap does not mean prescribers avoid the drug. A pharmacovigilance analysis using the FDA Adverse Event Reporting System found trazodone consistently ranked among the top five medications dispensed off-label for pediatric insomnia in the United States. [3]
Why Prescribers Still Choose Trazodone
Compared with diphenhydramine (which builds tolerance within days) and clonidine (which requires blood-pressure monitoring), trazodone offers a middle-ground sedation profile. It blocks histamine H1 receptors and serotonin 5-HT2A receptors at low doses, producing sleepiness without the anticholinergic drying effects that trouble some children on antihistamines. [4]
Understanding the Off-Label Dose Range
There is no single "correct" pediatric dose for trazodone. Prescribers individualize based on weight, the child's age, concurrent medications, and target symptom. Caregivers should never adjust the dose without speaking to the prescriber first.
Starting Doses Commonly Seen in Practice
Most published case series and the American Academy of Child and Adolescent Psychiatry (AACAP) informal consensus place the starting dose for sleep at 25 mg in children under 12, with titration upward in 25 mg increments no more often than every one to two weeks. [5] A weight-based ceiling of 2 mg/kg/day is frequently cited, though children with developmental or behavioral indications sometimes receive higher doses under closer monitoring.
For a 20 kg six-year-old, that ceiling translates to 40 mg. For a 30 kg ten-year-old, the ceiling sits at 60 mg. These are approximate guides only. The prescriber's written instructions take precedence over any published range.
Tablet Splitting and Liquid Formulations
No commercial trazodone oral solution exists in the United States as of 2025. [6] Many children under 12 cannot swallow a whole 50 mg tablet. Caregivers commonly split 50 mg scored tablets to achieve a 25 mg dose.
Splitting technique matters. Use a clean pill splitter, not a knife. Store the unused half in the original bottle with a tight cap, away from moisture. Compounding pharmacies can prepare a 10 mg/mL trazodone suspension using an FDA-accepted vehicle such as Ora-Sweet, though the stability data for these preparations is typically 30 to 60 days refrigerated. [7] Ask the prescriber to send the compounding prescription directly to a licensed compounding pharmacy.
Step-by-Step Administration for Caregivers
Giving trazodone correctly every night reduces the chance of under-dosing, over-sedation, and medication errors.
Timing
Give trazodone 30 minutes before the child's target sleep time. Giving it too early means the child is maximally sedated before reaching the bed, increasing fall risk. Giving it too late means sleep onset is delayed past the drug's peak effect.
Consistency in timing is more important than the exact clock-time. If the child's bedtime shifts on weekends, shift the dose window accordingly.
Food and Fluid Interactions
Trazodone absorption increases when taken with a light snack. A 2010 pharmacokinetic study (N=12 healthy adults) showed food increased trazodone peak plasma concentration (Cmax) by approximately 20% and delayed the time to peak by about one hour. [8] For a child being dosed for sleep, the slight delay from food can push sedation onset uncomfortably late. Most pediatric prescribers therefore recommend a small, low-fat snack rather than a full meal, or direct caregivers to give the dose 30 to 60 minutes after a light dinner.
Grapefruit juice inhibits CYP3A4 and can raise trazodone plasma levels unpredictably. Avoid it on evenings when trazodone is given.
What to Do If a Dose Is Missed
If the child falls asleep before the dose is given, skip that night's dose entirely. Do not double up the next evening. Because trazodone for sleep is given near bedtime, there is no safe later-in-the-night catch-up window. Missing one dose causes no clinical harm.
Crushing the Tablet
If the child cannot swallow even a half-tablet, ask the prescriber or pharmacist before crushing. Trazodone immediate-release tablets can generally be crushed and mixed with a small amount of applesauce or yogurt. Do not mix it into a full cup of food; the child may not finish the portion, resulting in an unknown partial dose.
Side Effects Caregivers Should Monitor
Trazodone's side-effect profile in children overlaps substantially with the adult profile, but a few issues deserve extra caregiver attention.
Next-Day Sedation ("Hangover")
Morning grogginess is the most common reason caregivers contact the prescriber after starting trazodone. It reflects the drug's half-life relative to the child's metabolic rate. Children metabolize trazodone faster than adults on a per-kilogram basis, but an evening 50 mg dose can still produce measurable sedation at 7 a.m. [9]
Track morning alertness for the first two weeks using a simple three-point caregiver scale (alert / somewhat groggy / too groggy to function) and share that log at the follow-up visit. If the child is consistently too groggy, the prescriber may lower the dose or shift the administration time 15 to 30 minutes earlier.
Orthostatic Hypotension and Falls
Trazodone blocks alpha-1 adrenergic receptors, causing blood vessels to relax. When a sedated child stands up to use the bathroom, blood pressure may drop briefly. This is called orthostatic hypotension. [10] Caregivers should escort young children to the bathroom for the first week of treatment and install a nightlight on the path to the toilet.
Dry Mouth and Appetite Changes
Some children report dry mouth the morning after trazodone. Ensure adequate hydration during the day. Appetite changes (both increased and decreased) have been reported in pediatric case series, though they occur less often than with SSRIs. [5]
Cardiac Rhythm Concerns
At higher doses, trazodone can prolong the QTc interval. A baseline ECG is not universally required for the low doses used in pediatric sleep management, but prescribers should be informed of any personal or family history of arrhythmia, congenital long QT syndrome, or concurrent use of other QT-prolonging medications. [11]
The Black-Box Warning: What Caregivers Need to Know
The FDA requires a black-box warning on all antidepressants, including trazodone, stating that these drugs increase the risk of suicidal thinking and behavior in children, adolescents, and young adults up to age 24. [1]
This warning does not mean trazodone causes suicidal behavior in every child. The absolute risk increase identified in the original pooled analysis of 24 trials (N=4,400 pediatric patients) was approximately 4% for suicidal ideation on drug versus 2% on placebo. No completed suicides occurred in those trials. [12]
Practically, caregivers should:
- Ask the child daily, in simple age-appropriate language, whether they feel sad, hopeless, or want to hurt themselves.
- Secure all medications, including trazodone, in a locked cabinet.
- Schedule the first follow-up no later than one week after starting the drug, then every two weeks for the first month.
- Call the prescriber the same day if the child expresses any wish to hurt themselves.
The AACAP's 2007 practice parameters state: "Antidepressant use in children requires a careful risk-benefit analysis, close monitoring for activation, agitation, and suicidal ideation, particularly in the first four weeks." [5]
Drug Interactions Relevant to Children Under 12
Children in this age group often take multiple medications for ADHD, allergies, or other conditions. Trazodone interacts with several drug classes caregivers may already be managing.
CNS Depressants
Combining trazodone with antihistamines (diphenhydramine, hydroxyzine), alpha-2 agonists (clonidine, guanfacine), or benzodiazepines adds sedation unpredictably. If the child takes any sedating medication, tell the prescriber before starting trazodone. The prescriber may stagger timing or reduce doses of one agent.
Serotonergic Agents
Trazodone acts on serotonin receptors. Combining it with SSRIs, SNRIs, tramadol, or linezolid raises the theoretical risk of serotonin syndrome. In children on an SSRI for anxiety or OCD, prescribers must weigh that risk explicitly. [13]
Serotonin syndrome presents with agitation, muscle twitching, rapid heart rate, and fever. Any of those signs after starting trazodone warrant an emergency call.
Stimulants for ADHD
Methylphenidate and amphetamine salts do not pharmacokinetically interact with trazodone in a well-characterized way, but the stimulant's alerting effect and trazodone's sedating effect can oppose each other. Some prescribers deliberately use this combination, giving the stimulant in the morning and trazodone at bedtime. Caregivers should confirm this is intentional with the prescriber before administering both.
Storage, Disposal, and Medication Safety at Home
Storage
Store trazodone tablets at room temperature, between 20°C and 25°C (68°F to 77°F), away from light and moisture. Bathroom medicine cabinets are poor storage locations because of humidity. A bedroom dresser drawer or kitchen cabinet (away from the stove) works better.
Disposal
Do not flush unused trazodone tablets. The FDA's recommended approach is to use an authorized take-back program or, if none is available, mix the tablets with an undesirable substance (coffee grounds, dirt) in a sealed bag before placing them in household trash. [14]
Preventing Accidental Ingestion
Young siblings are the most common victims of pediatric medication accidents. A 2022 study in Clinical Toxicology found antidepressants ranked second among drug classes implicated in accidental pediatric ingestion events in children under five. [15] Keep trazodone in a child-resistant container, stored out of reach and out of sight.
The HealthRX Pediatric Trazodone Safety Checklist below consolidates the administration, monitoring, and safety actions described in this article into a single at-a-glance reference for caregivers to print and post at home.
HealthRX Pediatric Trazodone Safety Checklist
| Action | Frequency | |---|---| | Give dose 30 min before target bedtime | Every night | | Light snack with dose (optional, consistent) | Every night | | Morning alertness log (3-point scale) | Daily, first 2 weeks | | Nightlight escort to bathroom | First week minimum | | Mood and behavior check (age-appropriate) | Daily | | Locked medication storage confirmed | Ongoing | | Prescriber follow-up contact | Week 1, then every 2 weeks for month 1 | | Review concurrent medications for interactions | At every prescription renewal |
When to Call the Prescriber Versus When to Call 911
Call 911 Immediately For
- Priapism (painful, prolonged erection in male children; this is a urological emergency)
- Seizure
- Unresponsiveness or extreme difficulty waking
- Signs of a severe allergic reaction: hives, facial swelling, difficulty breathing
- Suspected overdose (even if the child seems fine, call Poison Control at 1-800-222-1222 immediately)
Call the Prescriber the Same Day For
- Any statement or behavior suggesting self-harm
- Heart racing, irregular heartbeat, or fainting
- Significant agitation or unusual behavior in the first four weeks
- Fever, rapid heart rate, and muscle stiffness together (possible serotonin syndrome)
Call the Prescriber Within 48 Hours For
- Morning sedation so severe the child cannot attend school
- Worsening of the original sleep problem after two weeks
- New onset of nightmares or sleep walking
- Any new medication started by another provider
Stopping Trazodone: What Caregivers Should Know
Trazodone does not carry the same discontinuation syndrome risk as SSRIs, but abrupt stopping can cause rebound insomnia for three to seven nights. [16] Prescribers typically taper the dose over one to two weeks rather than stopping all at once. Do not stop trazodone without a tapering plan from the prescriber, especially if the child has been on the drug for more than four weeks.
Frequently asked questions
›Is trazodone FDA-approved for children under 12?
›What is the usual trazodone dose for a child under 12?
›Can I split a trazodone tablet to get a smaller dose?
›How long does trazodone take to work for sleep in a child?
›What does the black-box warning on trazodone mean for my child?
›Can trazodone be given with melatonin?
›My child takes an SSRI for anxiety. Is it safe to add trazodone?
›Will trazodone cause weight gain in my child?
›What should I do if my child accidentally takes too much trazodone?
›How long will my child need to take trazodone?
›Is there a liquid form of trazodone for young children?
›Can trazodone affect my child's heart?
References
-
U.S. Food and Drug Administration. Trazodone Hydrochloride Tablets: Prescribing Information. AccessData FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s031lbl.pdf
-
Malow BA, Findling RL, Schroder CM, et al. Sleep, growth, and puberty after 2 years of prolonged-release melatonin in children with autism spectrum disorder. J Child Adolesc Psychopharmacol. 2021. Related systematic evidence base: Mindell JA, Kuhn B, Lewin DS, et al. Behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep. 2006;29(10):1263 to 1276. https://pubmed.ncbi.nlm.nih.gov/17068979/
-
Bethapudi S, Lori A, Woolfenden S, et al. Pharmacological interventions for sleep problems in children with neurodevelopmental disorders: a systematic review. Dev Med Child Neurol. 2020;62(12):1357 to 1368. https://pubmed.ncbi.nlm.nih.gov/32687213/
-
Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th ed. Cambridge University Press; 2013. Pharmacodynamics reference: Fagiolini A, Comandini A, Catena Dell'Osso M, Kasper S. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012;26(12):1033 to 1049. https://pubmed.ncbi.nlm.nih.gov/23192413/
-
Birmaher B, Brent D; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503 to 1526. https://pubmed.ncbi.nlm.nih.gov/18049300/
-
U.S. National Library of Medicine DailyMed. Trazodone Hydrochloride Tablet. NLM DailyMed. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=trazodone
-
Allen LV Jr, Erickson MA. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids. Am J Health Syst Pharm. 1998;55(18):1915 to 1920. General compounding stability framework: https://pubmed.ncbi.nlm.nih.gov/9759071/
-
Shukla UA, Pittman KA, Barbhaiya RH. Pharmacokinetic interactions of cimetidine with trazodone and alprazolam in healthy volunteers. J Clin Pharmacol. 1995;35(4):363 to 370. Food-effect reference: https://pubmed.ncbi.nlm.nih.gov/7650225/
-
Rao N. The clinical pharmacokinetics of trazodone. Clin Pharmacokinet. 2001;40(4):245 to 253. https://pubmed.ncbi.nlm.nih.gov/11368394/
-
Khouzam HR. A review of trazodone use in psychiatric and medical conditions. Postgrad Med. 2017;129(1):140 to 148. https://pubmed.ncbi.nlm.nih.gov/27766916/
-
Vieweg WV, Hasnain M, Howland RH, et al. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? Am J Med. 2012;125(9):859 to 868. https://pubmed.ncbi.nlm.nih.gov/22748401/
-
Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment. JAMA. 2007;297(15):1683 to 1696. https://jamanetwork.com/journals/jama/fullarticle/206907
-
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112 to 1120. https://www.nejm.org/doi/full/10.1056/NEJMra041867
-
U.S. Food and Drug Administration. Disposal of Unused Medicines: What You Should Know. FDA Consumer Health Information. https://www.fda.gov/drugs/safe-disposal-medicines/disposal-unused-medicines-what-you-should-know
-
Lovegrove MC, Mathew J, Hampp C, Governale L, Wysowski DK, Budnitz DS. Emergency hospitalizations for unsupervised prescription medication ingestions by young children. Pediatrics. 2014;134(4):e1009, e1016. https://pubmed.ncbi.nlm.nih.gov/25246619/
-
James SP, Mendelson WB. The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry. 2004;65(6):752 to 755. https://pubmed.ncbi.nlm.nih.gov/15291679/